With unintended weight loss, You can't afford to wait.
Take control with Mirataz® (mirtazapine transdermal ointment).
Mirataz® gives your clients a practical way to manage their cat's unintended weight loss without administration of oral medication
Does not rely on the cat to eat to be medicated
First and only FDA-approved transdermal medication for weight gain in cats with a history of weight loss
Mirataz® demonstrated a 3.9% increase in body weight in cats with unintended weight loss in as little as 14 days1
Start Here
to place an order!
Important Safety Information As with all drugs, side effects may occur. Mirataz® (mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients. Do not use in cats treated with monoamine oxidase inhibitors (MAOIs). Not for human use. Keep out of reach of children. Wear gloves when handling/applying, wash hands after and avoid contact between the treated cat and people or other animals for 2 hours following application. Use with caution in cats with hepatic and kidney disease. Cat's food intake should be monitored upon discontinuation. Safety has not been evaluated in cats less than 2 kg, less than six months of age or in breeding, pregnant or lactating cats. The most common adverse reactions observed during clinical trials were application site reactions, behavioral abnormalities (vocalization and hyperactivity) and vomiting. Refer to the prescribing information for complete details or visit www.dechra-us.com.
1 Poole M, Quimby JM, Hu T, et al. A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss. J Vet Pharmacol Ther. 2019;42(2):179-188.
**All personal information collected will be handled in accordance with Dechra's Privacy Policy, learn more here.